Do dying patients have a “right to try” illegal drugs such as psilocybin and MDMA if they might alleviate end-of-life suffering from anxiety and depression? That question is now before one of the ...

Designing and Validating a Comprehensive Patient-Reported Outcomes Measure for Ambulatory Cancer Settings: The Revised Edmonton Symptom Assessment System for Cancer This prospective, longitudinal ...

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American Can the active ingredient in "magic mushrooms ...

Certain psychoactive substances can improve the mental health of terminally ill cancer patients—but few patients can currently access them. Psilocybin, the psychoactive chemical in psychedelic ...

Benzodiazepines like lorazepam can precipitate or worsen delirium, and are often avoided for patients with end-of-life delirium. Among cancer patients in a palliative care setting, those who received ...